Effect of Buprenorphine on the Ventilatory Response to Carbon Dioxide
Author(s) -
T. J. Baster,
J. M. Gibbs,
Tra-My Justine Richardson
Publication year - 1977
Publication title -
anaesthesia and intensive care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.494
H-Index - 62
eISSN - 1448-0271
pISSN - 0310-057X
DOI - 10.1177/0310057x7700500205
Subject(s) - buprenorphine , medicine , anesthesia , analgesic , opioid , antagonist , carbon dioxide , receptor , ecology , biology
Buprenorphine is a potent synthetic opioid-partial antagonist analgesic drug currently under clinical trial. When administered intravenously to human volunteers buprenorphine produced a significant depression of the ventilatory response to carbon dioxide stimulus for a period in excess of six hours.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom